Category - Executive Moves

Executive Moves

Global medical device executive Kenneth Knudson joins Profound as CCO

Profound Medical (NASDAQ:PROF; TSX:PRN) appointed accomplished global medical device industry veteran, Kenneth Knudson, as chief commercial officer to lead Profound’s worldwide sales, marketing and reimbursement...

January 5, 2022

Executive Moves

Ondine Biomedical appoints renowned Prof Trevor Jones to lead COVID-19 advisory board

Ondine Biomedical (LSE:OBI), appointed Prof. Trevor Jones, CBE FMedSci, to lead a new advisory board on the use of its pioneering photodisinfection-based technology to prevent and treat COVID-19. Ondine’s non-antibiotic...

December 15, 2021

Executive Moves

Talkiatry appoints Vanessa Cao as SVP of operations

In-network psychiatric care provider, Talkiatry, appointed Vanessa Cao as SVP of operations as the company prepares for a national rollout. With more than 10 years of experience in operations, Ms. Cao joins Talkiatry...

November 17, 2021

Executive Moves

Labster names Hope Frank as CMO

Hope Frank Closely-held Labster, a virtual learning platform for students, named Hope Frank as chief marketing officer as part of its continued mission to bring accessible and transformative STEM education (science...

November 17, 2021

Executive Moves

Cellares names leading bioethicist Dr. Ezekiel Emanuel to board of advisors

Ezekiel Emanuel Closely-held cell therapy manufacturer, Cellares, appointed Ezekiel Emanuel, M.D. and Ph.D., to its board of advisors. Dr. Emanuel is a bioethicist and currently vice provost for global initiatives, the...

November 16, 2021

Executive Moves

GeneTether bolsters management team to support growth

Closely-held GeneTether, a genome editing technology company, named Roland Boivin as CEO, Jean Jen as CFO and Peter Sampson, Ph.D., as VP of research and development. The appointments are intended to further position...

October 19, 2021

Executive Moves

Daniel Pearlstein joins POINT Biopharma in corporate strategy

Daniel Pearlstein was named associate director, corporate strategy, of POINT Biopharma (NASDAQ:PNT), which debuted on the Nasdaq Capital Market on July 1, 2021. Mr. Pearlstein was formerly EVP for...

September 27, 2021

Executive Moves

RNADD adds renowned pro sports team physician Michael Farber to advisory board

Michael Farber Closely-held RNA Disease Diagnostics appointed board-certified internist and professional sports physician, Michael Farber, M.D., to its advisory board. Dr. Farber is the medical director of executive...

September 2, 2021

Executive Moves

iBio names biotech veteran Chip Clark to the board

William (Chip) Clark iBio (NYSE:IBIO) appointed William (Chip) Clark to the board, effective immediately. Mr. Clark has more than 30 years of biotechnology and pharmaceutical experience, with a focus on business...

August 26, 2021

Executive Moves

IntelGenx strengthens board with atai appointments of Dr. Srinivas Rao and Frank Stegert

IntelGenx Technologies (TSXV:IGX; OTCQB:IGXT) named Dr. Srinivas (Srini) Rao, M.D., Ph.D., and Frank Stegert to the board, reflecting a previously disclosed purchaser rights agreement with atai Life Sciences AG. With...

August 4, 2021

Category - Executive Moves

Global medical device executive Kenneth Knudson joins Profound as CCO

Ondine Biomedical appoints renowned Prof Trevor Jones to lead COVID-19 advisory board

Talkiatry appoints Vanessa Cao as SVP of operations

Labster names Hope Frank as CMO

Cellares names leading bioethicist Dr. Ezekiel Emanuel to board of advisors

GeneTether bolsters management team to support growth

Daniel Pearlstein joins POINT Biopharma in corporate strategy

RNADD adds renowned pro sports team physician Michael Farber to advisory board

iBio names biotech veteran Chip Clark to the board

IntelGenx strengthens board with atai appointments of Dr. Srinivas Rao and Frank Stegert

General

More